Press release
Histone Deacetylase Inhibitors Market Set to Record Exponential Growth by 2019
Based on the classes, Histone Deacetylase Inhibitors Market are classified into class 1, class 2 and class 3 HDAC. HDAC inhibitors leads to accumulation of acetylated nuclear histones in both tumor and normal tissues, providing an alternate marker for the biological activity of HDAC inhibitors. Inhibition of HDAC also results in acetylation transcription factors such as GATA-1, p53 and estrogen receptor-alpha. HDIs are potent anti-proliferative agents with moderately little effect on normal tissues.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1927
Based on applications, histone deacetylase inhibitors are categorized into oncology, neurology and others diseases. Presently there are four approved HDI products in the market namely Vorinostat (Zolinza), Romidepsin (Istodax), Vidaza and Dacogen. Consequently, global biopharmaceutical companies are conducting research for its application in different indications.
North America leads the histone deacetylase inhibitors market with rapid acceptance of these products in this region. Globally, this market would be growing at a very rapid pace owing to a tremendous potential of this class of drugs in oncology therapy. Rising incidence of oncology and aging population would be the driving factors for this market.
Some of the key players in this market include Merck & Co., Inc., Celgene Corporation, Eisai Pharmaceuticals, Novartis, Acetylon Pharmaceuticals, Celleron Therapeutics, Envivo Pharmaceuticals and Pfizer, Inc. These companies are aiming to discover new products in this class, through prospective pipeline, collaborations and ventures.
View Report -
https://www.transparencymarketresearch.com/histone-deacetylase-inhibitors.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Histone Deacetylase Inhibitors Market Set to Record Exponential Growth by 2019 here
News-ID: 1008476 • Views: …
More Releases from Transparency Market Research
Autoinjectors Market to be Worth USD 173.9 Bn by 2036 - By Usability / By Route …
The global autoinjectors market has emerged as a vital segment within the injectable drug delivery ecosystem, demonstrating robust expansion supported by technological innovation and the increasing prevalence of chronic diseases worldwide. The market was valued at US$ 89.9 billion in 2025 and is projected to reach US$ 173.9 billion by 2036, registering a compound annual growth rate (CAGR) of 6.2% from 2026 to 2036.
Preview crucial insights and findings from our…
Argentina Car Care Products Market Outlook 2036: Market Size to Reach US$ 960.6 …
The Argentina car care products market continues to demonstrate steady, resilient growth, reflecting the country's large and aging vehicle fleet and rising consumer awareness around vehicle aesthetics and resale value. In 2025, the market was valued at US$ 641.1 million and is projected to expand to US$ 960.6 million by 2036, registering a compound annual growth rate (CAGR) of 3.8% from 2026 to 2036.
This growth trajectory underscores the essential nature…
Dental 3D Printing Market Outlook 2036: Explosive 26.3% CAGR Growth Driven by Cu …
The global dental 3D printing market is entering a phase of extraordinary expansion. Valued at US$ 5.1 Bn in 2025, the market is projected to surge to US$ 66.1 Bn by 2036, registering a robust compound annual growth rate (CAGR) of 26.3% from 2026 to 2036. This rapid growth reflects the accelerating shift of dental practices and laboratories toward digital, patient-specific manufacturing solutions.
Such a steep growth curve positions dental 3D…
Chromoendoscopy Agents Market Outlook 2036: Rising GI Disorder Burden and Advanc …
The global chromoendoscopy agents market was valued at US$ 0.16 billion in 2025 and is projected to reach US$ 0.28 billion by 2036, expanding at a CAGR of 5.2% from 2026 to 2036. The market is witnessing consistent growth due to the rising prevalence of gastrointestinal (GI) disorders, increasing demand for early cancer detection, and growing adoption of advanced endoscopic diagnostic techniques in hospitals and specialty clinics worldwide.
Get Your Sample…
More Releases for Histone
Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report
The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the…
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Marke …
The Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to…
Global Histone Deacetylase Inhibitors Market Research Report
This report studies the global Histone Deacetylase Inhibitors market status and forecast, categorizes the global Histone Deacetylase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 4SC AG Acetylon Pharmaceuticals Celleron Therapeutics Chroma Therapeutics CrystalGenomics Curis MEI Pharma Mirati Therapeutics Novartis…
Histone Deacetylase Inhibitors Market & Pipeline Insight2015
Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining steady state. Their involvement in diseases has been noted by investigators…
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline …
The latest report Histone Deacetylase 4 - Pipeline Review, H1 2017, outlays comprehensive information on the Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviewsalso reviews key players involved in Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics development…
Global Histone Deacetylase Inhibitors Market
Histone deacetylase (HDAC) is enzymes, which inhibits histone deacetylase by removing scetyl group from n-acetyl lysine amino acid. Histone deacetylase inhibitors are emerging as potential application in diagnosis, treatment and prognosis of cancer. It is also considered as a treatment option for hematological malignancies and plays important role in epigenetic or non-epigenetic regulation. The histone deacetylase inhibitors accumulates acetylated nuclear histone in tumors and normal tissues. Thus, the inhabitation results…
